Analysed STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) News Sources
This Obesity Drug Stock Has Jumped 60% as Phase 3 Plans Advance. A Fund Just Sold $4.7 Million
17-05-2026
fool.com
This Biotech Stock Is Up 355%. One Fund Added a $169 Million Position Last Quarter
24-05-2026
fool.com
Structure Therapeutics Announces Participation in Upcoming Investor Conferences
26-05-2026
yahoo.com
Structure Therapeutics Announces Publication in Nature Medicine Highlighting Phase 2b ACCESS Program of Aleniglipron for Obesity
05-06-2026
yahoo.com
Does Phase 2b Oral GLP-1 Data on Aleniglipron Change The Bull Case For Structure Therapeutics (GPCR)?
07-06-2026
yahoo.com
What is the current price of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)?
The current price of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) is $41.25.
STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) absolute price change since previous trading day?
The absolute price change of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) since the previous trading day is $3.48.
STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) percentage price change since previous trading day?
The percentage price change of STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) since the previous trading day is 9.2137%.
What is the most recent average sentiment score for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)?
The most recent average sentiment score for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) is 84 out of 100.
What is the most recent average sentiment for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)?
The most recent sentiment for STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ) is .
SEC-8K** Filing Available For STRUCTURE THERAPEUTICS INC (GPCR:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.